RESUMO
In this study, we report a facile fabrication of poly(ethylene glycol) (PEG) based bulk and micro-patterned hydrogels that are amenable to functionalization with thiol-bearing molecules using the metal-free radical 'thiol-ene' click reaction. The hydrogels were synthesized using photopolymerization of commercially available monomers, namely allyl methacrylate and PEG-methacrylate in the presence of a PEG-dimethacrylate based crosslinker. Swelling behaviour of these hydrogels could be tailored by varying the amount of the hydrophilic monomer in the feed as well as varying the length of the PEG-chain in the methacrylate monomer. Importantly, the extent of functionalization of these hydrogels could be readily tuned by varying the amount of the reactive allyl methacrylate monomer. Analysis of nitrogen content in the hydrogels after conjugation of cysteamine demonstrated that the amount of cysteamine incorporation was in correlation with the amount of allyl groups in the hydrogels. Three-dimensional hydrogel patterns were fabricated using micromolding in capillaries. Tuneable conjugation of a thiol-containing dye molecule and a ligand-mediated immobilization of streptavidin onto these hydrogel patterns were realized. It was found that the swellability of the hydrogel patterns control the diffusion of streptavidin into the interior of the hydrogel matrix. These bio-inert hydrogels could be appended with peptides to promote cellular adhesion. Furthermore, it was demonstrated that the photochemical thiol-ene based method of conjugation enables localized attachment of thiol-containing molecules within these reactive hydrogels.
RESUMO
Nanosized liposomal drug delivery systems are well suited for selective drug delivery at tumor sites. Celecoxib (CLX) is a highly hydrophobic cyclooxygenase-2 inhibitor that can reduce the incidence of colorectal polyps; however, the adverse cardiovascular effects limit its applicability. Here, we report a liposomal formulation of CLX using 1,2-Distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol. Encapsulation efficiency of the drug was greater than 70%; the release was slow and sustained with only 12%-20% of CLX released in the first 12 h. Flow cytometry and confocal microscopy studies using the colon cancer cell lines HCT-116 and SW620 showed significantly higher cellular association and internalization of the liposomes after incubation for 6 h when compared with 30 min. The liposomes did not colocalize with transferrin, but had a punctuate appearance, indicating vesicular localization. Cell proliferation was inhibited by 95% and 78%, respectively, in SW620 and HT29 cells after incubation with 600 µM liposomal CLX for 72 h. Moreover, cellular motility, as shown by a scratch wound healing assay, was also significantly (p = 0.006) inhibited when SW620 cells were incubated with 400 µM liposomal CLX. This is the first report of the successful encapsulation of CLX in a long-circulating liposomal formulation that could be effective against colorectal cancer.
